129 related articles for article (PubMed ID: 28107261)
21. Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
Monteil J; Maubon A; Leobon S; Roux S; Marin B; Renaudie J; Genet D; Fermeaux V; Aubard Y; Tubiana-Mathieu N
Anticancer Res; 2011 Nov; 31(11):3865-71. PubMed ID: 22110211
[TBL] [Abstract][Full Text] [Related]
22. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer.
Houvenaeghel G; Lelievre L; Rigouard AL; Buttarelli M; Jacquemier J; Viens P; Gonzague-Casabianca L
Gynecol Oncol; 2006 Jul; 102(1):74-9. PubMed ID: 16406062
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
[TBL] [Abstract][Full Text] [Related]
24. Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation?
Ferrandina G; Fanfani F; Ludovisi M; Fagotti A; Carbone A; Zannoni G; Guerriero M; Petrillo M; Scambia G
Gynecol Oncol; 2008 Jan; 108(1):220-5. PubMed ID: 17976708
[TBL] [Abstract][Full Text] [Related]
25. Pelvic and para-aortic lymphadenectomy are required to stage locally advanced cervical cancer.
Lavoué V; Bats AS; Daraï E
Gynecol Oncol; 2008 Jun; 109(3):427-8; author reply 428-9. PubMed ID: 17931697
[No Abstract] [Full Text] [Related]
26. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes.
Liang JA; Chen SW; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY
Int J Gynecol Cancer; 2014 Jun; 24(5):901-7. PubMed ID: 23975081
[TBL] [Abstract][Full Text] [Related]
27. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer.
Lee JY; Kim Y; Lee TJ; Jeon YW; Kim K; Chung HH; Kim HJ; Park SM; Kim JW
J Gynecol Oncol; 2015 Jul; 26(3):171-8. PubMed ID: 25925292
[TBL] [Abstract][Full Text] [Related]
29. Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes.
Moore KN; Gold MA; McMeekin DS; Walker JL; Rutledge T; Zorn KK
Gynecol Oncol; 2008 Mar; 108(3):466-71. PubMed ID: 18191994
[TBL] [Abstract][Full Text] [Related]
30. A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.
Lee YJ; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2017 Mar; 144(3):536-540. PubMed ID: 28108027
[TBL] [Abstract][Full Text] [Related]
31. Upper margin of para-aortic lymphadenectomy in cervical cancer.
Ouldamer L; Fichet-Djavadian S; Marret H; Barillot I; Body G
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):893-900. PubMed ID: 22553934
[TBL] [Abstract][Full Text] [Related]
32. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
33. Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.
Lea JS; Sheets EE; Duska LR; Miller DS; Schorge JO
Gynecol Oncol; 2002 Feb; 84(2):285-8. PubMed ID: 11812088
[TBL] [Abstract][Full Text] [Related]
34. Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis.
Yoon HI; Cha J; Keum KC; Lee HY; Nam EJ; Kim SW; Kim S; Kim YT; Kim GE; Kim YB
Radiat Oncol; 2015 Jan; 10():18. PubMed ID: 25582425
[TBL] [Abstract][Full Text] [Related]
35. Cervical cancer with paraaortic involvement: do patients truly benefit from tailored chemoradiation therapy? A retrospective study on 8 French centers.
Chantalat E; Vidal F; Leguevaque P; Lepage B; Mathevet P; Deslandres M; Motton S
Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():118-22. PubMed ID: 26295788
[TBL] [Abstract][Full Text] [Related]
36. Para-aortic lymph node metastases in locally advanced cervical cancer: Comparison between surgical staging and imaging.
Vandeperre A; Van Limbergen E; Leunen K; Moerman P; Amant F; Vergote I
Gynecol Oncol; 2015 Aug; 138(2):299-303. PubMed ID: 26007204
[TBL] [Abstract][Full Text] [Related]
37. Significance of numbers of metastatic and removed lymph nodes in FIGO stage IB1 to IIA cervical cancer: Primary surgical treatment versus neoadjuvant chemotherapy before surgery.
Kim HS; Kim JH; Chung HH; Kim HJ; Kim YB; Kim JW; Park NH; Song YS; Kang SB
Gynecol Oncol; 2011 Jun; 121(3):551-7. PubMed ID: 21334733
[TBL] [Abstract][Full Text] [Related]
38. Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment.
Del Carmen MG; Pareja R; Melamed A; Rodriguez J; Greer A; Clark RM; Rice LW
Gynecol Oncol; 2018 Sep; 150(3):406-411. PubMed ID: 30017539
[TBL] [Abstract][Full Text] [Related]
39. Prognostic implication of retrocrural lymph node involvement revealed by (18)F-FDG PET/CT in patients with uterine cervical cancer.
Im HJ; Yoon HJ; Lee ES; Kim TS; Kim JY; Chung JK; Kim SK; Park SY
Nucl Med Commun; 2014 Mar; 35(3):268-75. PubMed ID: 24253568
[TBL] [Abstract][Full Text] [Related]
40. The significance of abdominal para-aortic lymph node metastasis in patients with lower thoracic esophageal cancer.
Tanaka K; Yano M; Motoori M; Doki Y; Kishi K; Miyashiro I; Shingai T; Gotoh K; Noura S; Takahashi H; Ohue M; Yamada T; Ohigashi H; Ishikawa O
Dis Esophagus; 2012 Feb; 25(2):146-52. PubMed ID: 21762280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
